CVS GroupCVSGF 90 Market Cap is $1,080.0 Mil as of Jun. 29, 2026. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $18.82 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 694 Healthcare Providers & Services companies, CVS Group ranks better than 81.27% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CVS Group's share price for the quarter that ended in Dec. 2025 was $16.22. CVS Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 70.7 Mil. Therefore, CVS Group's market cap for the quarter that ended in Dec. 2025 was $1,146.9 Mil.
CVS Group's quarterly market cap
increased
from Dec. 2024 ($764.0 Mil) to Jun. 2025 ($1,248.3 Mil) but then
declined
from Jun. 2025 ($1,248.3 Mil) to Dec. 2025 ($1,146.9 Mil).
CVS Group's annual market cap
declined
from Jun. 2023 ($1,704.2 Mil) to Jun. 2024 ($986.3 Mil) but then
increased
from Jun. 2024 ($986.3 Mil) to Jun. 2025 ($1,248.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CVS Group's Enterprise Value for Today is $1,429.6 Mil.
CVS Group (OTCPK:CVSGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
CVS Group Market Cap Related Terms
CVS Group Market Cap Historical Data
* Premium members only.
The historical data trend for CVS Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, CVS Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's Market Cap distribution charts can be found below:
* The bar in red indicates where CVS Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
CVS Group's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Group (CVSGF) has a Market Cap of $1,080.0 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CVS Group and its competitors. According to the industry distribution chart, CVS Group ranks #130 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 18.7%.
Is CVS Group's Market Cap too high?
CVS Group's current Market Cap is $1,080.0 Mil. The Healthcare Providers & Services industry median Market Cap is 93.08. CVS Group's value of $1,080.0 Mil is 1060.4% above this industry median. Based on the distribution chart, CVS Group ranks #130 out of 694 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, CVS Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #130 out of 694 companies for Market Cap. This places CVS Group in the top 19% of its industry — outperforming the majority of peers. The industry median Market Cap is 93.08. CVS Group's value of $1,080.0 Mil is 1060.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current Market Cap of $1,080.0 Mil is 1060.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current Market Cap is $1,080.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.82, compared to a current price of $16.55 — trading 12.1% below its estimated fair value. The current Market Cap is $1,080.0 Mil and 1060.4% above the Healthcare Providers & Services industry median of 93.08. CVS Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CVS Group (CVSGF), the current Market Cap is $1,080.0 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $16.55 is trading 12.1% below its estimated GF Value™ of $18.82.
GuruFocus considers CVS Group to be Modestly Undervalued.
Key valuation signals for CVSGF:
Market Cap: $1,080.0 Mil
GF Value™: $18.82 vs. price of $16.55 (12.1% below fair value)
Industry Position: 1060.4% above the Healthcare Providers & Services median (#130 of 694)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score
Get the complete analysis for CVSGF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
